Bai Song Mei
Vermogen: 5 M $ op 30-09-2026
Vermogen: 5 M $ op 30-09-2026
Dr. Bai Song Mei is a Chief Medical Officer at City Therapeutics, Inc. Dr. Mei was previously employed as a Chief Medical Officer & Executive Vice President by Editas Medicine, Inc. and a Senior Global Project Head-Rare Disease by Sanofi.
He received his doctorate degree from the University of Toledo (Ohio).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,44% | 15-10-2026 | 228.743 ( 0,44% ) | 5 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| EDITAS MEDICINE, INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2024 |
| SANOFI | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Toledo (Ohio)
University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Bengbu Medical College
Bengbu Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan University School of Law
Wuhan University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau